Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Liver disease | Image credit: Crystal light - stock.adobe.com

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

By Pearl Steinzor

June 13th 2025

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent study, urging early detection and comprehensive care.

DASH diet | Image credit: Albi - stock.adobe.com

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

By Pearl Steinzor

June 10th 2025

vials of insulin | Image credit: Sherry Young - stock.adobe.com

AI Matches Physician Accuracy in Insulin Dosing for T2D

By Laura Joszt, MA

May 30th 2025

Type 2 diabetes graphic | Image Credit: greenapple78 - stock.adobe.com

Concurrent Hypertension, Type 2 Diabetes Linked to Higher Mortality Risk

By Brooke McCormick

May 29th 2025

Insulin cost | Image credit: Pixel-Shot - stock.adobe.com

Diabetes Health Gains Outpace Economic Progress, Study Finds

By Pearl Steinzor

May 16th 2025

More News

October 31st 2023

Safety vs Price in the Generic Drug Market: Metformin

Ben Teasdale, MPhil Amber Hudspeth, MS Kaury Kucera, PhD David Light, BS Jill Nailor, RPh Shannon Williams, BS Arnold Milstein, MD Kevin A. Schulman, MD

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls.

US and Mexico flags | Image Credit: Rawf8 – stock.adobe.com

October 25th 2023

How Can Family Affect Diabetes Management in Mexican American Adults?

Hayden E. Klein

Interviews highlight the importance of culturally-tailored diabetes education to address health care disparities in the Mexican American community.

Steak on cutting board | Image Credit: Rishieka – stock.adobe.com

October 20th 2023

High Red Meat Consumption Linked to Increased Diabetes Risk

Hayden E. Klein

New research found that people who routinely eat high amounts of red meat have a 62% higher risk of developing type 2 diabetes, supporting dietary recommendations to limit red meat consumption.

October 19th 2023

Use of Second-Generation Antidiabetic Medication Among a Nationally Representative Sample

Bang Truong, PhD Yuexin Li, MS Jingyi Zheng, PhD Jingjing Qian, PhD

Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.

October 12th 2023

What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management

AJMC Staff

Blood tests offer a less invasive and more accessible means of detecting Alzheimer disease; Democrats address a year-long Adderall shortage; A new study shows significantly improved clinical outcomes in Type 2 diabetes management with a digital behavioral therapy app.

Hospital sign | Image Credit: Spiroview Inc. – stock.adobe.com

October 11th 2023

For Patients With Diabetes, Review Finds CVD to Be Leading Cause of Hospital Admissions

Hayden E. Klein

Ischemic and coronary heart disease were the 2 major cardiovascular disease (CVD) subtypes contributing to hospital admissions among patients with diabetes.

Medical stethoscope and dollar bills | Image Credit: Kuzmick – stock.adobe.com

October 7th 2023

Patients With NASH and Type 2 Diabetes Face Costly Financial Burden

Abigail Brooks, MA

Annualized costs for the 24-month study period were highest among patients with both NASH and T2D, highlighting the incremental cost of adding an additional diagnosis for comorbid NASH or T2D.

Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.

September 24th 2023

Dr Matthew Crowley Discusses Key Advantages and Challenges of Telehealth Among Underserved Populations

Pearl Steinzor

Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine, discusses telehealth initiatives at Duke Health, as well as overcoming virtual challenges and barriers that underserved and underinsured patient populations who need diabetes care face.

FDA approved | Image credit: Aquir – stock.adobe.com

September 22nd 2023

FDA Grants Approval for Empagliflozin in Chronic Kidney Disease

Hayden E. Klein

This approval marks the fourth endorsement by the FDA for empagliflozin, all of which have been linked to the EMPOWER program.

Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,

September 17th 2023

Dr Susan Spratt Discusses Diabetes Management Services at Duke Health

Pearl Steinzor

Susan Spratt, MD, senior medical director, Duke Population Health Management Office, breaks down the the prevalence of diabetes in the United States and discusses current diabetes initiatives at Duke Health.

September 15th 2023

Measuring Continuity of Care for Diabetes: Which Visits to Include?

Kevin R. Riggs, MD, MPH Caroline A. Presley, MD, MPH April A. Agne, MPH Carrie R. Howell, PhD Lei Huang, PhD, MS, MBA Michael J. Mugavero, MD, MHSc Emily B. Levitan, ScD Andrea L. Cherrington, MD, MPH

This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.

Diabetes | Image credit: Minerva Studio - stock.adobe.com

September 13th 2023

PCOS in Pregnant Women With Diabetes Linked to High Insulin Requirements, Weight Gain

Pearl Steinzor

However, women with type 2 diabetes and polycystic ovary syndrome (PCOS) in pregnancy did not have worse neonatal outcomes, a study found.

doctor with tablet pc and pregnant woman at clinic | Image credit: Syda Productions – stock.adobe.com

September 11th 2023

Women With Gestational Diabetes Have Elevated 30-Year Mortality Risk, Study Suggests

Hayden E. Klein

New research suggests an association between gestational diabetes history and mortality over 30 years, regardless of whether it manifests into type 2 diabetes.

September 6th 2023

Dr Nikolaus Marx: New Recommendations on Lifestyle Modification, Glucose-Lowering Agents for Comorbid Diabetes, CVD

Hayden E. Klein

A patient-centered approach on top of a multifactorial approach will help patients adhere to lifestyle modifications, said Nikolaus Marx, MD, professor of medicine/cardiology and head of the Department of Internal Medicine, University Hospital Aachen, Germany.

September 1st 2023

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

David Kerr, MBChB, DM Ian Duncan, PhD Enrico Repetto, MD Rana Maroun, PharmD, PhD Alexander Wu, MSc Christopher Perkins, MS Gert Bergman, PhD, MSc Francesco Giorgino, MD, PhD

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.

August 22nd 2023

Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims Data

Jaehyeon Yun, PhD Giovanni Filardo, PhD, MPH Vishal Ahuja, PhD, MBA, MASc Michael E. Bowen, MD, MPH Daniel F. Heitjan, PhD

A statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.

August 21st 2023

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

M. Thomas Bateman Jr, PharmD, BCACP Ryan Nguyen, PharmD, BCPS Ashwini B. Navathe, PharmD, BCPS, BCPPS Caitlin McCarthy, PharmD, BCPP

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.

August 18th 2023

Non–Face-to-Face Care Management and Service Utilization in Patients With Diabetes

Charles Stoecker, PhD Elizabeth Nauman, PhD, MPH Alessandra N. Bazzano, PhD Eboni G. Price-Haywood, MD, MPH Yilin Yoshida, PhD, MPH Lizheng Shi, PhD, MSPharm, MA

CMS began reimbursement for non–face-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.

Hand holding a blood glucose meter measuring blood sugar, the background is a stethoscope and chart file | Image Credit: xb100 – stock.adobe.com

August 10th 2023

Experts Call for Health System Action to Reduce Hypoglycemia Risk in Older Adults With Diabetes

Hayden E. Klein

According to one panelist, the leading causes of hypoglycemia in older adults are insufficient nutrition and taking the wrong dose or type of insulin, both of which can be addressed at the patient and system level.

August 4th 2023

Type 2 Diabetes Can Increase Hospital Bed-Days, Study Says

Hayden E. Klein

A Hong Kong study revealed how much type 2 diabetes (T2D) can increase hospital bed-days based on condition, age, sex, and other factors.

CGM -system of continuous monitoring of glucose on child's arm. | Image credit: habrovich – stock.adobe.com

August 3rd 2023

Why Time in Range Matters for Diabetes Care Beyond A1C

Hayden E. Klein

Panelists at the American Diabetes Association 83rd Scientific Sessions explained how time in range is emerging as a crucial target in diabetes management.

Vials and syringe on white table with background windows | Image Credit – Davizro Photography - stock.adobe.com

July 29th 2023

Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills

Luke Halpern

Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.

$Hand holding on foot anatomy with red highlight on painful area. Toe pain may cause from bone fracture, tendinitis, ligament sprain, gout arthritis or bunion disease. medical symptom | Image Credit: Joel bubble ben - stock.adobe.com$

July 27th 2023

SGLT2is Reduce Recurrent Gout Flare More Than DPP-4is in Patients With Diabetes, Study Says

Hayden E. Klein

Initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2is) was associated with a 34% lower rate of recurrent gout flare compared with initiation of dipeptidyl peptidase 4 inhibitors (DPP-4is).